Faculty, Staff and Student Publications

Authors

    Language

    English

    Publication Date

    4-1-2024

    Journal

    Cell Oncology

    DOI

    10.1007/s13402-023-00886-7

    PMID

    37821797

    PMCID

    PMC12973968

    PubMedCentral® Posted Date

    10-12-2023

    PubMedCentral® Full Text Version

    Post-print

    Abstract

    Purpose: Cancer cells with stem cell-like properties may contribute to cancer development and therapy resistance. The advancement of multi-omics technology has sparked interest in exploring cancer stemness from a multi-omics perspective. However, there is a limited number of studies that have attempted to subtype cancer by combining different types of stem cell signatures.

    Methods: In this study, 10,323 cancer specimens from 33 TCGA cancer types were clustered based on the enrichment scores of six stemness gene sets, representing two types of stem cell backgrounds: embryonic stem cells (ESCs) and hematopoietic stem cells (HSCs).

    Results: We identified four subtypes of pan-cancer, termed StC1, StC2, StC3 and StC4, which displayed distinct molecular and clinical features, including stemness, genome integrity, intratumor heterogeneity, methylation levels, tumor microenvironment, tumor progression, responses to chemotherapy and immunotherapy, and survival prognosis. Importantly, this subtyping method for pan-cancer is reproducible at the protein level.

    Conclusion: Our findings indicate that the ESC signature is an adverse prognostic factor in cancer, while the HSC signature and ratio of HSC/ESC signatures are positive prognostic factors. The subtyping of cancer based on ESC and HSC signatures may provide insights into cancer biology and clinical implications of cancer.

    Keywords

    Humans, Hematopoietic Stem Cells, Neoplasms, Embryonic Stem Cells, Prognosis, Tumor Microenvironment, Gene Expression Regulation, Neoplastic, Neoplastic Stem Cells, Gene Expression Profiling, Biomarkers, Tumor, Pan-cancer, Subtyping, Multi-omics, Embryonic stem cell signature, Hematopoietic stem cell signature

    Published Open-Access

    yes

    Share

    COinS
     
     

    To view the content in your browser, please download Adobe Reader or, alternately,
    you may Download the file to your hard drive.

    NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.